Yield10 Bioscience, Inc. (YTEN) Misses Q3 EPS by 6c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.71), $0.06 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $111 thousand versus the consensus estimate of $124.67 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Reading (RDI) Tops Q2 EPS by 4c